Core Laboratories (MEX:CLB) Cyclically Adjusted PS Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CLB Core Laboratories Inc MEX:CLB
59 GF Score
Price MXN856.38
GF Value MXN1,179.25
! 3 Warning Signs
View Full Analysis

What is Core Laboratories Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Core Laboratories  (MEX:CLB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Core Laboratories Cyclically Adjusted PS Ratio Related Terms


Core Laboratories Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Core Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories Cyclically Adjusted PS Ratio Chart

Core Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 1.08 1.01 1.10 1.08

Core Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.82 1.08 1.13 0.79

MEX:CLB vs EROK, OIS, NGS: Cyclically Adjusted PS Ratio Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories Cyclically Adjusted PS Ratio vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Cyclically Adjusted PS Ratio falls into.


MEX:CLB
59GF Score
Core Laboratories Inc MEX:CLB
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Core Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Core Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Core Laboratories's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=47.218/333.9520*333.9520
=47.218

Current CPI (Jun. 2026) = 333.9520.

Core Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 62.597 241.428 86.586
201612 67.452 241.432 93.301
201703 66.494 243.801 91.082
201706 64.449 244.955 87.865
201709 66.680 246.819 90.220
201712 75.677 246.524 102.515
201803 69.469 249.554 92.963
201806 77.495 251.989 102.701
201809 76.406 252.439 101.078
201812 76.897 251.233 102.216
201903 73.368 254.202 96.386
201906 72.454 256.143 94.463
201909 76.467 256.759 99.456
201912 66.624 256.974 86.582
202003 80.399 258.115 104.021
202006 60.073 257.797 77.819
202009 51.850 260.280 66.526
202012 50.849 260.474 65.193
202103 48.200 264.877 60.770
202106 50.182 271.696 61.681
202109 51.480 274.310 62.673
202112 55.492 278.802 66.469
202203 49.586 287.504 57.597
202206 51.593 296.311 58.147
202209 53.897 296.808 60.642
202212 53.626 296.797 60.339
202303 48.727 301.836 53.912
202306 46.158 305.109 50.521
202309 45.865 307.789 49.764
202312 45.832 306.746 49.897
202403 45.102 312.332 48.224
202406 50.105 314.175 53.259
202409 55.339 315.301 58.612
202412 56.541 315.605 59.828
202503 54.055 319.799 56.447
202506 51.744 322.561 53.571
202509 52.417 324.800 53.894
202512 54.056 324.054 55.707
202603 47.671 330.213 48.211
202606 47.218 333.952 47.218

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Core Laboratories (MEX:CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of MXN856.38 is trading 27.4% below its estimated GF Value™ of MXN1,179.25.

Key valuation signals for MEX:CLB:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: MXN1,179.25 vs. price of MXN856.38 (27.4% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges CLB:USAHJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
59GF Score

Get the complete analysis for MEX:CLB

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN856.38
Price
MXN1,179.25
GF Value